Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
eli lilly
3
×
fda
indiana blog main
indiana top stories
life sciences
national blog main
amgen
chronic migraine
indiana
teva pharmaceutical
alprazolam
boehringer ingelheim
boston blog main
calcitonin gene-related peptide
cgrp inhibitors
colucid pharmaceuticals
drug enforcement administration
drugs
empagliflozin
episodic migraine
europe
europe blog main
europe top stories
lasmiditan
migraine
migraine research foundation
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
slgt2 inhibitor
the institute for clinical and economic review
triptans
type 1 diabetes
type 2 diabetes
What
approval
3
×
drug
eli
3
×
fda
lilly
migraine
new
won
acute
addresses
announced
approved
bid
boehringer
causes
class
condition
decades
decision
developed
diabetes
expand
fallen
friday
giant
giving
headache
ingelheim
lasmiditan
late
lilly’s
marketed
marks
medication
medicines
medicine’s
oks
pain
patients
pharmaceutical
Language
unset
Current search:
eli
×
approval
×
" eli lilly "
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines